Health Catalyst(HCAT)

Search documents
Health Catalyst(HCAT) - 2020 Q3 - Earnings Call Transcript
2020-11-11 04:09
Health Catalyst, Inc. (NASDAQ:HCAT) Q3 2020 Earnings Conference Call November 10, 2020 5:00 PM ET Corporate Participants Adam Brown - SVP, Investor Relations Dan Burton - Chief Executive Officer Patrick Nelli - Chief Financial Officer Conference Call Participants Robert Jones - Goldman Sachs Anne Samuel - JPMorgan Ryan Daniels - William Blair Jessica Tassan - Piper Sandler Sandy Draper - Truist Securities Elizabeth Anderson - Evercore Stephanie Davis - SVB Leerink John Ransom - Raymond James David Grossman ...
Health Catalyst(HCAT) - 2020 Q3 - Quarterly Report
2020-11-10 22:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its cha ...
Health Catalyst(HCAT) - 2020 Q2 - Earnings Call Transcript
2020-08-12 03:57
Health Catalyst, Inc. (NASDAQ:HCAT) Q2 2020 Earnings Conference Call August 11, 2020 5:00 PM ET Company Participants Adam Brown - SVP, IRn Dan Burton - CEO Patrick Nelli - CFO Conference Call Participants Robert Jones - Goldman Sachs Anne Samuel - JPMorgan Ryan Daniels - William Blair Sean Wieland - Piper Sandler Sandy Draper - Truist Securities Elizabeth Anderson - Evercore Stephanie Davis - SVB Leerink Richard Close - Canaccord Genuity David Grossman - Stifle Daniel Grosslight - Citi David Larson - Verity ...
Health Catalyst(HCAT) - 2020 Q2 - Quarterly Report
2020-08-11 22:54
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its charter) ...
Health Catalyst(HCAT) - 2020 Q1 - Earnings Call Transcript
2020-05-13 02:56
Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2020 Earnings Conference Call May 12, 2020 8:30 AM ET Company Participants Adam Brown - SVP, IR Dan Burton - CEO Patrick Nelli - CFO Conference Call Participants Robert Jones - Goldman Sachs Anne Samuel - JPMorgan Ryan Daniels - William Blair Sean Wieland - Piper Sandler Mike Newshel - Evercore Stephanie Davis - SVB Leerink Sandy Draper - SunTrust Richard Close - Canaccord Genuity Sean Dodge - RBC Capital Markets Operator Ladies and gentlemen, thank you for standing by ...
Health Catalyst(HCAT) - 2020 Q1 - Quarterly Report
2020-05-12 22:37
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Or (Address of principal executive offices, including zip code) (801) 708-6800 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 ...
Health Catalyst(HCAT) - 2019 Q4 - Earnings Call Transcript
2020-02-28 03:17
Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2019 Earnings Conference Call February 27, 2020 5:00 PM ET Company Participants Adam Brown - SVP, IR Daniel Burton - CEO & Director Patrick Nelli - CFO Conference Call Participants Robert Jones - Goldman Sachs Group Anne Samuel - JPMorgan Chase & Co. Ryan Daniels - William Blair & Company Sean Wieland - Piper Sandler & Co. Michael Newshel - Evercore ISI Stanislav Berenshteyn - SunTrust Robinson Humphrey Operator Ladies and gentlemen, thank you for standing by, and welc ...
Health Catalyst(HCAT) - 2019 Q4 - Annual Report
2020-02-27 23:42
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K _______________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its charter) ___ ...
Health Catalyst(HCAT) - 2019 Q3 - Earnings Call Transcript
2019-11-13 03:44
Health Catalyst, Inc. (NASDAQ:HCAT) Q3 2019 Earnings Conference Call November 12, 2019 5:00 PM ET Company Participants Adam Brown - Senior Vice President, Investor Relations Dan Burton - Chief Executive Officer Patrick Nelli - Chief Financial Officer Conference Call Participants Anne Samuel - JP Morgan Robert Jones - Goldman Sachs Jared Hasse - William Blair Sean Wieland - Piper Jaffray Michael Newshel - Evercore Daniel Grosslight - SVB Leerink Operator Ladies and gentlemen, thank you for standing by and we ...
Health Catalyst(HCAT) - 2019 Q3 - Quarterly Report
2019-11-13 00:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of incorporation or organization) Delaware 45-3337483 (I.R.S. Employer Identification Number) For the quarterly period ended September 30, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fr ...